The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of 1261 metastatic cancer patients evaluated by comprehensive molecular profiling (CMP) including next-gen sequencing (NGS) from a single institution.
 
Jason Claud Chandler
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Janssen
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech/Roche; GlaxoSmithKline; Lilly; Onyx
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen
 
Ari M. Vanderwalde
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caris Life Sciences; Genentech
Research Funding - Amgen; AstraZeneca; Genentech/Roche; Lilly; Merck; Millennium
 
Bradley G. Somer
Research Funding - Aragon Pharmaceuticals; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; GlaxoSmithKline; Incyte; Merck; Millennium; Newlink Genetics; OncoGenex; Roche/Genentech; Wellstat Therapeutics
 
Gregory A. Vidal
Consulting or Advisory Role - Lilly
Speakers' Bureau - Pfizer
Research Funding - AstraZeneca; Genentech/Roche; GTx; Lilly; Merck; Newlink Genetics; Puma Biotechnology
 
Lee Steven Schwartzberg
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Helsinn Therapeutics; Spectrum Pharmaceuticals; Tesaro; Teva
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech